--- templates/history.tpl 2001/02/02 09:35:08 1.1 +++ templates/history.tpl 2001/03/12 19:21:49 1.3 @@ -1,96 +1,16 @@ - - - - - - + + +
- - - - -
-
-

 

-
    + + + + +{section name=h loop=$history} + + + + +{/section} - -
  • 1921 - “Kastel” d.d. is founded -
  • 1928 - “Kastel” d.d. moves to Zagreb -
  • 1936 the company becomes one of the first - global sulfonamide producers - -
  • 1940 Plibah-Bannat Institute for production - of biological and chemical medicines - -
  • 1941 - Plibah become PLIVA-State Institute for Production - of Medicines & Vaccines -
  • 1952 - PLIVA Research Institute is founded -
  • 1953 the first quantities of Vitamin C - are manufactured using in-house technology - -
  • 1959 production of Vitamin B and oxytetracycline - is begun -
  • 1971 methacycline is patented - -
  • 1980 - PLIVA’s original macrolide antibiotic-azithromycin - is patented and protected -
  • 1986 - PLIVA signs a licensing agreement with US company - Pfizer, granting Pfizer an exclusive right for - the sale of azithromycin in the USA and western - Europe -
  • 1988 - PLIVA launched azithromycin under the name of - Sumamed -
  • 1991 Pfizer launched azithromycin under - the name of Zithromax -
  • 1991 - Croatia becomes an independent state and PLIVA - begins its privatization process -
  • 1993 - PLIVA becomes a joint stock - company -
  • 1996 - The listing of PLIVA’s shares on - the London Stock Exchange marks the 75th anniversary - of PLIVA -
  • 1997 - Acquisition of majority stake of Polfa - - Krakow (presently - PLIVA Krakow) -
  • 1998 new azithromycin production facility was open -
  • 1998 - Acquisition of Slovak Yeast Producer, - Fermenta - -
  • 1999 - Acquisition of FARMACOM, - of MIXIS GENETICS Ltd., and of LACHEMA (presently - - PLIVA LACHEMA)
    • -
  • 2000 - Acquisition of Dominion -
    • - - - - - - -
    {$h/history.year}{$h/history.description}
    - - - - -
    -
    +